Loading

Journal of Veterinary Medicine and Research

Determination of Immune Response of Cevac New L® (La Sota Strain) Vaccine in Pigeon

Research Article | Open Access

  • 1. Department of Medicine, Sylhet Agricultural University, Bangladesh
  • 2. Department of Medicine, Sylhet Agricultural University, Bangladesh
  • 3. Department of Medicine, Sylhet Agricultural University, Bangladesh
  • 4. Department of Medicine, Sylhet Agricultural University, Bangladesh
  • 5. Department of Medicine, Sylhet Agricultural University, Bangladesh
+ Show More - Show Less
Corresponding Authors
Matiur Rahman, Assistant Professor, Department of Medicine, Sylhet Agricultural University, Bangladesh, Sylhet-3100
ABSTRACT

Newcastle disease is a devastating poultry disease all over the world including Bangladesh. The present study was conducted to investigate the immune response of ND live vaccines Cevac New L® (La Sota strain) in pigeons during the period from January, 2014 to June, 2014. For the purposes of this experiment 40 pigeons were divided into 2 groups. In group A (n=20) and B (n=20,unvaccinated control) vaccination was performed twice with Cevac New L® at day 5 and 21 of age i/o. Serum antibody titre was evaluated by the means of hemagglutination inhibition test (HI). The Mean±SD of HI titre (log2X) of group A was 4.75±0.64, 5.65±0.59, 6.85±0.67, 7.55±0.51,6.35±0.67, 5.20±0.77 at day12, 19, 28, 35, 42 and 49 of post vaccination respectively. It was observed that serum Ab level was gradually increased from day 12 to day 35 and declined slowly after day 42 in group, leading to good protection to the pigeon against ND. There was a significant (p<0.05) differences between the HI titre of group A and B. From the result, it was revealed that Cevac New L® (La Sota Strain) produced better immune response in the pigeon body against ND in respect of HI Abtitres response.

CITATION

Rahman M, Hasan R, Ahmed S, Tanbir Ahmed ABM, Hasan M, et al. (2018) Determination of Immune Response of Cevac New L® (La Sota Strain) Vaccine in Pigeon. J Vet Med Res 5(1): 1116.

KEYWORDS
  • Antibody
  • Immune response
  • Newcastle disease
  • Ocular; Pigeon
  • Antibody titre
  • Vaccine
INTRDUCTION

Newcastle disease is a highly contagious, rapid spreading nature and World Organization for Animal Health (OIE) listed notifiableviral disease affecting all poultry species, characterized by gastrointestinal, respiratory and nervous signs with high mortality (up to 100 %) [1]. ND is a major problem to commercial poultry industry throughout the world [2]. Epizootics of ND in poultry continue to occur on a regular basis in Africa, Asia and Central and South America while sporadic epizootics occur in Europe [3]. In Bangladesh ND is mostly due to velogenic strain [4]. During 1981 to 1985, infections of racing and show pigeons with an APMV-1 became worldwide, causing a frequently fatal disease primarily associated with neurological signs. Newcastle disease is endemic in Bangladesh with prevalence of viscerotrophic velogenic strain [5]. Effective control of ND relies on the use of safe and good vaccines. Live vaccines prepared with lentogenic and mesogenic strain of NDV are now more commonly used in pigeon. This is because live vaccines can be produced on a large scale at a relatively low cost. The vaccines are easy to administer on a large scale and rapidly stimulate humoral, cell-mediated and mucosal surface immunity in the vaccinated birds. Vaccination as directed by [4]. includes administration of live lentogenic vaccine (BCRDV) of F-strain by inta-ocular inoculation followed by a live mesogenic vaccine (RDV) of mukteswar strain by intramuscular route maintenance of sustainable level of neutralizing antibody in the serum of vaccinated birds. Various live vaccines containing lentogenic strains of NDV such as B1 , La Sota, VG/GA and ND clone are brought by several importers. The best-known lentogenic live vaccines are Hitchner B1 and La Sota strain, both of which hadbeen extensively used [6].

Newcastle disease vaccines produced in Bangladesh are not sufficient to meet up the demand of growing poultry industry. As a result a good number of live lentogenic and mesogenic as well as inactivated Newcastle disease vaccines are being imported and marketed. Vaccination against ND in poultry is very common in Bangladesh. But in pigeon vaccination against ND is very rare because of lack of proper scientific knowledge regarding vaccine and vaccination against ND. In most of the cases, the vaccines were found effective against ND incase of chicken. Although there was no study found regarding immune response of ND vaccines in pigeon except Vaccination of birds either killed or live NDV vaccines might induced cell mediated humoral local and passive immunity. Antibody titers against NDV were usually evaluated by means of hemagglutination inhibition test (HI) was widely used including Bangladesh. That’s why research aims to study the assessment of NDV “Lasota strain” vaccines (Cevac New L®) induced immune response determined by HI test.

MATERIALS AND METHODS

The study was carried out in experimental shed of department of Medicine and the laboratory of Microbiology and Immunology, Sylhet Agricultural University, Sylhet, during the period of January 2014 to July 2014. Pigeons were collected from the local market of Sylhet with no history of vaccination against ND and carried to the experimental shed. The pigeon were reared under strict bio-security and prerequisite required for rearing such birds. All pigeons were supplied with nutritional feed and fresh drinking water through the entire experiment. Among all pigeons, 40 pigeons were grouped into A and B and the pigeons of group A were vaccinated with Cevec New L® at day 5 and day 21 respectively while pigeons of B group were kept as unvaccinated control. Blood was collected individually from the brachial vein at day 4, 12, 19, 28, 35, 42 and 49 with the sterile syringe and needle and placed the syringe in a slanting position for 1 hour at room temperature. Then the clot was detached from the wall of the syringe carefully, allowed it to settle down. Serum was then collected carefully and aseptically, transferred into small vials and then centrifuged at 1500 rpm for 15 min to obtain clear serum were stored at-20C temperature until used [7]. Antibody titer for NDV was determined from each serum sample using the OIE HI test protocol. 2% and 0.5% cRBC was prepared prior to HA and HI test. Mature chicken was used for the collection of blood for the preparation of red blood cell. For this, sterile syringe and needle containing anticoagulants at the art of 1ml for 9ml blood. Following the collection, it was washed with PBS and centrifuged @1000rpm for 10 min. The suspension of plasma materials and supernatant was discarded and then cRBC was collected. After that 0.5% and 2% cRBC were prepared for slide Haemagglutination test, HA tests and HI test respectively [8]. The unused cRBC suspension was stored at 40C until used. Log2 X geometric mean titre (GMT) of HI Ab was calculated for each occasion in each group. The data were analyzed with used of paired‘t’ test by Statistical Package for Social Science (SPSS) version 20.0 programme to determine the significant differences in HI titres of pigeon between groups after primary and secondary vaccination [9].

RESULTS AND DISCUSSIONS

Maternally derived antibody (MDA) of unvaccinated control group B was measured from day 4 to day 49 and the titres were 3.95, 3.05, 1.70, 0.95, 0.30, 0.00 and 0.00 at day 4, 12, 19, 28, 35, 42 and 49 respectively (Figure 2). It was observed that the MDA was persisted at a suitable level up to day 12. But MDA levels started to decline after day 4 and reached at a trace level after 28 day. MDA level became totally zero at day 42. This findings strongly supported by the findings of [10]. He reported that the persistence of MDA up to 27 days of age of birds. [11] was found that the MDA level persisted at a suitable level up to 16 days and it started to decline after 16 days and reached at a negligible level after 26 days. [5,12] who stated that the persistence of MDA in chickens were day 15 to 20 of age. According to [13] HI titre3 (log2 X) was protective titre for pigeon. From the result it was also observed that there were no significant differences (p>0.05) of MDA titres between group A and B at day 4. Pigeons of A group vaccinated with a live vaccine Cevac New L® (La Sota strain) at day 5 and day 21 i/o following which sera were obtained from 20 randomly selected pigeons on each occasion of day12, 19, 28, 35, 42 and 49 of age given the HI titre (log2 X) 4.75±0.64, 5.65±0.59, 6.85±0.67, 7.55±0.51, 6.35±0.67 and 5.20±0.77 respectively after vaccination (Figure 1). The HI titre increased immediately just after primary vaccination and the HI titre was found highest after secondary vaccination at day 35. The HI titre was gradually declined after day 35. But this HI titre gave satisfactory protection to the pigeons against ND. After primary vaccination, it was observed that the vaccinated groups of pigeons produced satisfactory immune response compared to those of unvaccinated control group. Intra-ocular vaccination was chosen based on the assumption that this route would make all pigeons received the same dose which was corroborated by reports showing that the ocular route was more efficient [14] and of high antibody titres in white-tailed eagles after intranasal La Sota vaccine [15].

The highest antibody titre was found at day 35 produced by the group A, vaccinated with Cevac New L (Live La Sota strain) and these levels gradually decreased at day 42 and day 49. But HI Ab titer of this group after secondary vaccination increased significantly (p<0.05; day 19 vs. day 35) [16], concluded that secondary vaccination yielded HI titre that was significantly higher than the HI titre after single vaccination. The outcome of the experiment was similar with the findings of [17]. He reported that live lentogenic ND vaccines produced an antibody titre of log2 4 to log2 6 . After administration of primary and secondary vaccine A groups responded quickly for the production of Ab and reached highest Abtitre after 2 weeks of vaccination. This was happened because administration of live La Sota strain vaccine which produced higher immune response. But declination process was comparatively slow in case of La Sota strain vaccine. [6] also reported that the best known lentogenic live vaccines were La So ta strain and Hitchner B1 , both of which have been extensively used in birds. This indicated that La Sota strain of Cevac New L® vaccine might be more immunogenic.

CONCLUSIONS AND RECOMMENDATIONS

ND is a devastating poultry disease causing about 40%-60% of total annual mortality among the infectious diseases in poultry industry in Bangladesh. Pigeons with infected by ND causing frequently fatal disease primarily associated with neurological signs. Vaccination is the proper way to prevent the disease. In this study, one commercial live vaccine, Cevac New L® (La Sota Strain) was used for the vaccination of the pigeons of group A at day 5 and day 21i/o. It was observed that the mentioned vaccine efficiently induced immune response in pigeons to protect ND. The Cevac New L® (La Sota Strain) vaccine may be used for the prevention and control of ND of pigeons in Bangladesh. Further studies need to develop an appropriate vaccination programme for pigeons with live ND vaccines.

ACKNOWLEDGEMENT

This study was the MS thesis of 1st author. The author was very much grateful to Professor Dr.Md. Rafiqul Islam, Professor Dr. ATM Mahbub-E-Elahi, Professor Dr. Md. Masudur Rahman, Professor Dr. Md. Mukter Hossain, Dr. Md. Bashir Uddin, Dr. Md. Mahfujur Rahman, Sylhet Agricultural University, for providing all necessary information, logistics support, guidance to complete this thesis smoothly.

COMPETING INTEREST

Authors have declared that no competing interests exist. There is absolutely no conflict of interest between the authors and producers of the products, because we do not intend to use these products as an avenue for any litigation but for the advancement of knowledge. Also, the research was not funded by the producing company rather it was funded by personal efforts of the 1st author.

REFERENCES

1. Oie, 2012. Newcastle Disease. Manual of Diagnostic Tests and Vaccines for Terrestrial Animals. Chapter 2.3.14.

2. Alexander DJ, EW Aldous, MCM. Fuller. The Long View: A Selective Review of 40 Years of Newcastle Disease Research. Avian Pathol. 2012; 41: 329-335.

3. Hines L, Miller CL. Avian Paramyxovirus Serotype-1: A Review of Disease Distribution, Clinical Symptoms and Laboratory Diagnostics. Veterinary Medicine International. 2012.

4. Chowdhury SI, TIMFR Chowdhury, AJ Sarker, MM Amin, Determination of An Optimum Age for Primary Newcastle Disease Vaccination of Chicks Having Maternal Antibody. Bang Vet J. 1981; 15: 19-17.

5. Aldous EW, JK Mynn, J Banks, DJ Alexander, A Molecular Epidemiological Study of Avian Paramyxovirus Type 1 (Newcastle Disease Virus) Isolates By Phylogenetic Analysis of A Partial Nucleotide Sequence of the Fusion Protein Gene. Avian Pathol. 2003; 32: 239-256.

6. Jeon WJ, EK Lee, YJ Lee, OM Jeong, YJ Kim, JH Kwon, et al. Protective Efficacy Of Commercial Inactivated Newcastle Disease Virus Vaccines In Chickens Against A Recent Korean Epizootic Strain. J. Vet. Sci. 2008; 9: 295-300.

7. Cheesbrough M. Medical Laboratory Manual for Tropical Countries. Vol. Ii. Microbiology, 1985; 443-445.

8. Oi.E, 2009. Newcastle Disease. In: Manual Of Standards for Diagnostic Tests and Vaccines (Ed. D. J. Alexander) Iv, Pp. 221-232. Office International Epizootics, Paris.

9. Beri GC. Business Statistics, 2ndedition, Tata Mcgraw-Hill Publishing Company Limited, New Delhi, India. 2005.

10. Mahmud MS, MT Hossain, P Monoura MM Amin. Comparative Efficacy of Avinew (Vg/Ga Strain) and Bcrdv (F Strain) Vaccines against Newcastle Disease in Broiler Chickens. Bangl J Vet. Med. 2007; 5: 19- 23.

11. Ahmed AI. Assessment of The Immune Response Using Nd Clone 30 Vaccine Through Eye Drop And Drinking Water In Ross 308 And Cobb 500. Al-Anbar J. Vet. Sci. 2013; 6: 1.

12. Shil NC, MM Amin, MB Rahman, Evaluation of Antibody Production Following Single Vaccination With Bcrdv, Izovac B1 , Hitchner And Cevac New L in Broiler Chicks. M.S. Thesis Submitted To The Department of Microbiology And Hygiene. Faculty of Vet. Science, Bau Mymensingh. 2006.

13. Allan WH, RE Gough. A Standard Haemagglutination Inhibition Test For Newcastle Disease (1) Comparision Of Macro And Micro Methods. Vet Rec. 1974; 95: 120-123.

14. Thekisoe MMO, PA Mbati, SPR Bisschop. Different Approaches to the Vaccination of Free Ranging Village Chickens against Newcastle Disease In Qwa-Qwa. South Africa. Vet. Microbiol. 2004; 101: 23-30.

15. Bailey TA, U Wernery, JH Samour, JL Naldo. Antibody Response of Kori Bustards (Ardotiskori) And Houbara Bustards (Chlamydotisundulata) To Live And Inactivated Newcastle Disease Vaccines. J. Zoo Wildlife Med. 1998; 29: 441-450.

16. Shuaib M, M Ashfaque, R Sajjad-Ur, MK Mansoor, I Yousaf, Comparative Immune Response of Broiler Chicks to Newcastle Disease Vaccine (La Sota Strain). Pakistan Vet. J. 2003; 23: 91-93.

17. Alexander DJ. Newcastle Disease and Other Avian Paramyxoviridae Infections, Disease of Poultry, North America, Lowa. 1997; 541-569.

Rahman M, Hasan R, Ahmed S, Tanbir Ahmed ABM, Hasan M, et al. (2018) Determination of Immune Response of Cevac New L® (La Sota Strain) Vaccine in Pigeon. J Vet Med Res 5(1): 1116.

Received : 11 Dec 2017
Accepted : 05 Jan 2018
Published : 06 Jan 2018
Journals
Annals of Otolaryngology and Rhinology
ISSN : 2379-948X
Launched : 2014
JSM Schizophrenia
Launched : 2016
Journal of Nausea
Launched : 2020
JSM Internal Medicine
Launched : 2016
JSM Hepatitis
Launched : 2016
JSM Oro Facial Surgeries
ISSN : 2578-3211
Launched : 2016
Journal of Human Nutrition and Food Science
ISSN : 2333-6706
Launched : 2013
JSM Regenerative Medicine and Bioengineering
ISSN : 2379-0490
Launched : 2013
JSM Spine
ISSN : 2578-3181
Launched : 2016
Archives of Palliative Care
ISSN : 2573-1165
Launched : 2016
JSM Nutritional Disorders
ISSN : 2578-3203
Launched : 2017
Annals of Neurodegenerative Disorders
ISSN : 2476-2032
Launched : 2016
Journal of Fever
ISSN : 2641-7782
Launched : 2017
JSM Bone Marrow Research
ISSN : 2578-3351
Launched : 2016
JSM Mathematics and Statistics
ISSN : 2578-3173
Launched : 2014
Journal of Autoimmunity and Research
ISSN : 2573-1173
Launched : 2014
JSM Arthritis
ISSN : 2475-9155
Launched : 2016
JSM Head and Neck Cancer-Cases and Reviews
ISSN : 2573-1610
Launched : 2016
JSM General Surgery Cases and Images
ISSN : 2573-1564
Launched : 2016
JSM Anatomy and Physiology
ISSN : 2573-1262
Launched : 2016
JSM Dental Surgery
ISSN : 2573-1548
Launched : 2016
Annals of Emergency Surgery
ISSN : 2573-1017
Launched : 2016
Annals of Mens Health and Wellness
ISSN : 2641-7707
Launched : 2017
Journal of Preventive Medicine and Health Care
ISSN : 2576-0084
Launched : 2018
Journal of Chronic Diseases and Management
ISSN : 2573-1300
Launched : 2016
Annals of Vaccines and Immunization
ISSN : 2378-9379
Launched : 2014
JSM Heart Surgery Cases and Images
ISSN : 2578-3157
Launched : 2016
Annals of Reproductive Medicine and Treatment
ISSN : 2573-1092
Launched : 2016
JSM Brain Science
ISSN : 2573-1289
Launched : 2016
JSM Biomarkers
ISSN : 2578-3815
Launched : 2014
JSM Biology
ISSN : 2475-9392
Launched : 2016
Archives of Stem Cell and Research
ISSN : 2578-3580
Launched : 2014
Annals of Clinical and Medical Microbiology
ISSN : 2578-3629
Launched : 2014
JSM Pediatric Surgery
ISSN : 2578-3149
Launched : 2017
Journal of Memory Disorder and Rehabilitation
ISSN : 2578-319X
Launched : 2016
JSM Tropical Medicine and Research
ISSN : 2578-3165
Launched : 2016
JSM Head and Face Medicine
ISSN : 2578-3793
Launched : 2016
JSM Cardiothoracic Surgery
ISSN : 2573-1297
Launched : 2016
JSM Bone and Joint Diseases
ISSN : 2578-3351
Launched : 2017
JSM Bioavailability and Bioequivalence
ISSN : 2641-7812
Launched : 2017
JSM Atherosclerosis
ISSN : 2573-1270
Launched : 2016
Journal of Genitourinary Disorders
ISSN : 2641-7790
Launched : 2017
Journal of Fractures and Sprains
ISSN : 2578-3831
Launched : 2016
Journal of Autism and Epilepsy
ISSN : 2641-7774
Launched : 2016
Annals of Marine Biology and Research
ISSN : 2573-105X
Launched : 2014
JSM Health Education & Primary Health Care
ISSN : 2578-3777
Launched : 2016
JSM Communication Disorders
ISSN : 2578-3807
Launched : 2016
Annals of Musculoskeletal Disorders
ISSN : 2578-3599
Launched : 2016
Annals of Virology and Research
ISSN : 2573-1122
Launched : 2014
JSM Renal Medicine
ISSN : 2573-1637
Launched : 2016
Journal of Muscle Health
ISSN : 2578-3823
Launched : 2016
JSM Genetics and Genomics
ISSN : 2334-1823
Launched : 2013
JSM Anxiety and Depression
ISSN : 2475-9139
Launched : 2016
Clinical Journal of Heart Diseases
ISSN : 2641-7766
Launched : 2016
Annals of Medicinal Chemistry and Research
ISSN : 2378-9336
Launched : 2014
JSM Pain and Management
ISSN : 2578-3378
Launched : 2016
JSM Women's Health
ISSN : 2578-3696
Launched : 2016
Clinical Research in HIV or AIDS
ISSN : 2374-0094
Launched : 2013
Journal of Endocrinology, Diabetes and Obesity
ISSN : 2333-6692
Launched : 2013
Journal of Substance Abuse and Alcoholism
ISSN : 2373-9363
Launched : 2013
JSM Neurosurgery and Spine
ISSN : 2373-9479
Launched : 2013
Journal of Liver and Clinical Research
ISSN : 2379-0830
Launched : 2014
Journal of Drug Design and Research
ISSN : 2379-089X
Launched : 2014
JSM Clinical Oncology and Research
ISSN : 2373-938X
Launched : 2013
JSM Bioinformatics, Genomics and Proteomics
ISSN : 2576-1102
Launched : 2014
JSM Chemistry
ISSN : 2334-1831
Launched : 2013
Journal of Trauma and Care
ISSN : 2573-1246
Launched : 2014
JSM Surgical Oncology and Research
ISSN : 2578-3688
Launched : 2016
Annals of Food Processing and Preservation
ISSN : 2573-1033
Launched : 2016
Journal of Radiology and Radiation Therapy
ISSN : 2333-7095
Launched : 2013
JSM Physical Medicine and Rehabilitation
ISSN : 2578-3572
Launched : 2016
Annals of Clinical Pathology
ISSN : 2373-9282
Launched : 2013
Annals of Cardiovascular Diseases
ISSN : 2641-7731
Launched : 2016
Journal of Behavior
ISSN : 2576-0076
Launched : 2016
Annals of Clinical and Experimental Metabolism
ISSN : 2572-2492
Launched : 2016
Clinical Research in Infectious Diseases
ISSN : 2379-0636
Launched : 2013
JSM Microbiology
ISSN : 2333-6455
Launched : 2013
Journal of Urology and Research
ISSN : 2379-951X
Launched : 2014
Journal of Family Medicine and Community Health
ISSN : 2379-0547
Launched : 2013
Annals of Pregnancy and Care
ISSN : 2578-336X
Launched : 2017
JSM Cell and Developmental Biology
ISSN : 2379-061X
Launched : 2013
Annals of Aquaculture and Research
ISSN : 2379-0881
Launched : 2014
Clinical Research in Pulmonology
ISSN : 2333-6625
Launched : 2013
Journal of Immunology and Clinical Research
ISSN : 2333-6714
Launched : 2013
Annals of Forensic Research and Analysis
ISSN : 2378-9476
Launched : 2014
JSM Biochemistry and Molecular Biology
ISSN : 2333-7109
Launched : 2013
Annals of Breast Cancer Research
ISSN : 2641-7685
Launched : 2016
Annals of Gerontology and Geriatric Research
ISSN : 2378-9409
Launched : 2014
Journal of Sleep Medicine and Disorders
ISSN : 2379-0822
Launched : 2014
JSM Burns and Trauma
ISSN : 2475-9406
Launched : 2016
Chemical Engineering and Process Techniques
ISSN : 2333-6633
Launched : 2013
Annals of Clinical Cytology and Pathology
ISSN : 2475-9430
Launched : 2014
JSM Allergy and Asthma
ISSN : 2573-1254
Launched : 2016
Journal of Neurological Disorders and Stroke
ISSN : 2334-2307
Launched : 2013
Annals of Sports Medicine and Research
ISSN : 2379-0571
Launched : 2014
JSM Sexual Medicine
ISSN : 2578-3718
Launched : 2016
Annals of Vascular Medicine and Research
ISSN : 2378-9344
Launched : 2014
JSM Biotechnology and Biomedical Engineering
ISSN : 2333-7117
Launched : 2013
Journal of Hematology and Transfusion
ISSN : 2333-6684
Launched : 2013
JSM Environmental Science and Ecology
ISSN : 2333-7141
Launched : 2013
Journal of Cardiology and Clinical Research
ISSN : 2333-6676
Launched : 2013
JSM Nanotechnology and Nanomedicine
ISSN : 2334-1815
Launched : 2013
Journal of Ear, Nose and Throat Disorders
ISSN : 2475-9473
Launched : 2016
JSM Ophthalmology
ISSN : 2333-6447
Launched : 2013
Journal of Pharmacology and Clinical Toxicology
ISSN : 2333-7079
Launched : 2013
Annals of Psychiatry and Mental Health
ISSN : 2374-0124
Launched : 2013
Medical Journal of Obstetrics and Gynecology
ISSN : 2333-6439
Launched : 2013
Annals of Pediatrics and Child Health
ISSN : 2373-9312
Launched : 2013
JSM Clinical Pharmaceutics
ISSN : 2379-9498
Launched : 2014
JSM Foot and Ankle
ISSN : 2475-9112
Launched : 2016
JSM Alzheimer's Disease and Related Dementia
ISSN : 2378-9565
Launched : 2014
Journal of Addiction Medicine and Therapy
ISSN : 2333-665X
Launched : 2013
Annals of Public Health and Research
ISSN : 2378-9328
Launched : 2014
Annals of Orthopedics and Rheumatology
ISSN : 2373-9290
Launched : 2013
Journal of Clinical Nephrology and Research
ISSN : 2379-0652
Launched : 2014
Annals of Community Medicine and Practice
ISSN : 2475-9465
Launched : 2014
Annals of Biometrics and Biostatistics
ISSN : 2374-0116
Launched : 2013
JSM Clinical Case Reports
ISSN : 2373-9819
Launched : 2013
Journal of Cancer Biology and Research
ISSN : 2373-9436
Launched : 2013
Journal of Surgery and Transplantation Science
ISSN : 2379-0911
Launched : 2013
Journal of Dermatology and Clinical Research
ISSN : 2373-9371
Launched : 2013
JSM Gastroenterology and Hepatology
ISSN : 2373-9487
Launched : 2013
Annals of Nursing and Practice
ISSN : 2379-9501
Launched : 2014
JSM Dentistry
ISSN : 2333-7133
Launched : 2013
Author Information X